ANGELES, Thelma S.,ATOR, Mark A.,CHENG, Mangeng M.,DORSEY, Bruce,HUDKINS, Robert L.,RUGGERI, Bruce A.
申请号：
HK16112659.9
公开号：
HK1224293A
申请日:
2016.11.03
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
This application describes the use of the compound (I) or a salt thereof, either alone or in combination with other therapeutically active agents, for the treatment of particular cancers, including any solid or hematological cancer in which AXL or c-Met is over-expressed.
